Andexxa Blood Clot Risks Lead to FDA Questions Regarding Safety of the Reversal Agent for Xarelto, Eliquis
Xarelto Side Effects More Likely to Result in Death than Warfarin for Afib Patients with Heart Disease: Study
Side Effects of Blood Thinners, Diabetes Drugs Are Leading Causes of ER Visits Due to Medications: Study
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Xarelto Aortic Aneurysm Lawsuit Filed Over Wrongful Death March 31, 2017 Irvin Jackson Add Your Comments According to allegations raised in a new wrongful death lawsuit, the side effects of Xarelto caused an aortic aneurysm that ultimately took the life of a Virginia man. The complaint (PDF) was filed by Jeraelyn B. Jude in the U.S. District Court for the Eastern District of Louisiana on March 20, following the death of Earnest W. Jude in January 2016. Johnson & Johnson, it’s Janssen subsidiary, and Bayer Healthcare are named as defendants, indicating that the drug makers failed to adequately warn users and the medical community about the link between Xarelto and aortic aneurysm injuries, as well as other bleeding risks associated with the controversial anticoagulant. Learn More About Xarelto Lawsuits Side Effects of Xarelto May Increase Risk of Uncontrollable Bleeding. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Xarelto Lawsuits Side Effects of Xarelto May Increase Risk of Uncontrollable Bleeding. Learn More SEE IF YOU QUALIFY FOR COMPENSATION According to the lawsuit, Ernest Jude took Xarelto for just a week before suffering an aortic aneurysm on January 9, 2016. As a result of the injury, he died on January 13, which the lawsuit indicates was the direct result of his use of Xarelto. “The use of Xarelto without appropriate blood monitoring, dose adjustment and twice a day dosing can cause major, life-threatening bleeding events,” the complaint states. “Physicians using Xarelto have to be able to balance the dose so that the blood is thinned enough to reduce the risk of stroke, but not thinned so much as to increase the risk for a major bleeding event.” There are currently more than 15,000 Xarelto lawsuits pending throughout the federal court system, which each raise similar allegations, indicating that the manufacturers withheld important information and warnings about the potential bleeding side effects of Xarelto, as well as the lack of an effective antidote that would have allowed doctors to reverse the blood thinning effects of the medication. The cases are centralized before U.S. District Judge Eldon Fallon in the Eastern District of Louisiana as part of an MDL, or multidistrict litigation. While most of the lawsuits deal with bleeding events allegedly cause by Xarelto, the latest case focuses on an aortic aneurysm injury. Aortic aneurysm is a painful and potentially serious condition involving a bulge in the aorta, where the walls of the artery have weakened. They can cause severe chest pain, as well as carry the risk of rupturing. Aortic aneurysms pose a serious health risk and usually require invasive surgery to treat. Xarelto Bleeding Problems Xarelto (rivaroxoaban) is a new-generation anticoagulant that was introduced in 2011, as an alternative to Coumadin (warfarin), which has been the go-to anticoagulant treatment for decades. The drug is part of a new class of medications, which have been promoted as easier to use than warfarin. However, since the drugs have hit the market, there have been a large number of reports involving severe and sometimes fatal bleeding problems with Xarelto and other members of this new class, including Pradaxa and Eliquis. While all blood thinners may cause bleeding, the side effects of warfarin can be quickly reversed with a widely known antidote. However, there was no Xarelto reversal agent when the drug was introduced. Former users who are now pursuing lawsuits allege that the drug makers failed to adequately warn doctors about the lack of an antidote, which led to severe and uncontrollable bleeds. Similar claims were raised in the litigation over Pradaxa, which was the first member of this class introduced in October 2010, one year before Xarelto hit the market. About 4,000 Pradaxa lawsuits were ultimately filed by users of that drug who suffered bleeding injuries. Following several years of litigation, the manufacturer of that medication ultimately agreed to pay $650 million in Pradaxa settlements just before the first bellwether trials were set to begin, with an average of about $150,000 per claim. As Xarelto bleeding lawyers continue to review potential cases for individuals prescribed the anticoagulant throughout the United States, the number of complaints has surpassed the number of claims involved in the Pradaxa litigation, as the drug has become more widely used in recent years. In recent months, there have also been an increasing number of Eliquis lawsuits filed over this newer member of the class, once again raising similar allegations that the drug maker failed to warn about the bleeding risk. Last week, the U.S. Judicial Panel on Multidistrict Litigation (JPML) heard oral arguments over whether to consolidate and centralize the federal Eliquis bleeding cases before one judge as part of a separate MDL. Tags: Aortic Aneurysm, Bayer, Bleeding, Blood Thinners, Johnson & Johnson, Xarelto Image Credit: test caption More Xarelto Lawsuit Stories Andexxa Blood Clot Risks Lead to FDA Questions Regarding Safety of the Reversal Agent for Xarelto, Eliquis November 21, 2024 Xarelto Side Effects More Likely to Result in Death than Warfarin for Afib Patients with Heart Disease: Study September 1, 2022 Side Effects of Blood Thinners, Diabetes Drugs Are Leading Causes of ER Visits Due to Medications: Study October 15, 2021 4 Comments Mark July 11, 2023 I had 3 dvt’s in my past. Doctor put me on Xarylto in 2019… thought I had a PE yesterday.7/10/23.. CT scan shows no clots but a Thorasic Aortic Aneurysm…4.9 cm … is sending me to a cardiac surgeon.. Mark September 14, 2021 I had an arterial outpatient procedure done ended up in the hospital with an sudoanyism and an aorta aneurism and a dvt now I’m on blood thinners which was supposed to be a simple pr ocedure Bethany October 27, 2019 My mother in law just passed away sunday oct 20 2019. She has been taking this medication for a while now. We had no warning. Just complaining of severe stomach pain for the day. The doctors were suprised that she even made it to the hospital. They said that she had an aortic aneurysm. And that if she had not been taking Xarelto they might have been able to reverse the bleeding but did not have enough time. Carolyn July 1, 2019 My father just father just died of an aortic aneurysm two months ago. He didn’t have major heart problems at all. He was on Xarelto for a year and a half then switched to eliquis in December 2018. No warning at all. Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Lawsuit Alleges Intracranial Meningioma From Depo-Provera Resulted in Need for Lifelong Medical Monitoring (Posted: today) A Depo-Provera lawsuit claims a woman will need medical monitoring for the rest of her life, after developing an intracranial meningioma caused by the use of the birth control shot. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Sign Ups Expected To Continue as First Brain Tumor Cases Prepared for Trial (05/23/2025)Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (05/15/2025)Depo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025) Court Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (Posted: today) Following the first federal bellwether trial expected to begin in September 2025, a group of four additional Valsartan lawsuits will be prepared for a second wave of trials. MORE ABOUT: VALSARTAN LAWSUITOrder Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)Parties Propose Schedules for Second Wave of Valsartan Bellwether Lawsuits (02/20/2025) AFFF Kidney Cancer Lawsuits Proposed For Oct. 20, 2025 Bellwether Trial Date (Posted: yesterday) Plaintiffs lawyers have outlined the order in which they believe three AFFF lawsuits should go to trial, indicating that each involves an individual diagnosed with kidney cancer after drinking from the same contaminated water source in Pennsylvania. MORE ABOUT: AFFF LAWSUIT3M PFAS Water Contamination Settlement Results in $450M Payout to New Jersey (05/14/2025)Court Urged To Combine 5 AFFF Lawsuits For First MDL Bellwether Trial (05/08/2025)Additional AFFF Ulcerative Colitis Lawsuits Added to Bellwether Discovery Pool (04/29/2025)
Andexxa Blood Clot Risks Lead to FDA Questions Regarding Safety of the Reversal Agent for Xarelto, Eliquis November 21, 2024
Xarelto Side Effects More Likely to Result in Death than Warfarin for Afib Patients with Heart Disease: Study September 1, 2022
Side Effects of Blood Thinners, Diabetes Drugs Are Leading Causes of ER Visits Due to Medications: Study October 15, 2021
Lawsuit Alleges Intracranial Meningioma From Depo-Provera Resulted in Need for Lifelong Medical Monitoring (Posted: today) A Depo-Provera lawsuit claims a woman will need medical monitoring for the rest of her life, after developing an intracranial meningioma caused by the use of the birth control shot. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Sign Ups Expected To Continue as First Brain Tumor Cases Prepared for Trial (05/23/2025)Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (05/15/2025)Depo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)
Court Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (Posted: today) Following the first federal bellwether trial expected to begin in September 2025, a group of four additional Valsartan lawsuits will be prepared for a second wave of trials. MORE ABOUT: VALSARTAN LAWSUITOrder Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)Parties Propose Schedules for Second Wave of Valsartan Bellwether Lawsuits (02/20/2025)
AFFF Kidney Cancer Lawsuits Proposed For Oct. 20, 2025 Bellwether Trial Date (Posted: yesterday) Plaintiffs lawyers have outlined the order in which they believe three AFFF lawsuits should go to trial, indicating that each involves an individual diagnosed with kidney cancer after drinking from the same contaminated water source in Pennsylvania. MORE ABOUT: AFFF LAWSUIT3M PFAS Water Contamination Settlement Results in $450M Payout to New Jersey (05/14/2025)Court Urged To Combine 5 AFFF Lawsuits For First MDL Bellwether Trial (05/08/2025)Additional AFFF Ulcerative Colitis Lawsuits Added to Bellwether Discovery Pool (04/29/2025)